You can buy or sell Novavax and other stocks, options, ETFs, and crypto commission-free!
Novavax, Inc. Common Stock, also called Novavax, is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. Read More It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. The firm's vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
Edited Transcript of NVAX earnings conference call or presentation 11-Mar-20 8:30pm GMT
Q4 2019 Novavax Inc Earnings Call ROCKVILLE Mar 28, 2020 (Thomson StreetEvents) -- Edited Transcript of Novavax Inc earnings conference call or presentation We
Novavax Shares Rally On Flu Vaccine Study Results: What You Need To Know
Novavax, Inc. (NASDAQ: NVAX), which was in the news recently on account of its COVID-19 vaccine development program, is in the spotlight yet again Tuesday. Flu
— per share
Expected Apr 30, After Hours